• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

类风湿关节炎中的血管生成:致病及临床意义

Angiogenesis in rheumatoid arthritis: pathogenic and clinical significance.

作者信息

Szekanecz Z, Szegedi G, Koch A E

机构信息

Department of Medicine, Northwestern University Medical School, Chicago, IL 60611, USA.

出版信息

J Investig Med. 1998 Feb;46(2):27-41.

PMID:9549225
Abstract

In summary, angiogenesis, the formation of new blood vessels, is important in leukocyte extravasation and thus the pathogenesis of RA. The outcome of neovascularization highly depends on the imbalance between angiogenic and angiostatic mediators produced in the rheumatoid synovium. Therefore, angiogenesis research is important for the understanding of the pathogenesis of inflammatory arthritis. In addition, existing and potential angiostatic drugs may be useful for future therapy of RA.

摘要

总之,血管生成,即新血管的形成,在白细胞渗出以及类风湿性关节炎的发病机制中起着重要作用。新血管形成的结果高度依赖于类风湿滑膜中产生的促血管生成和血管生成抑制介质之间的失衡。因此,血管生成研究对于理解炎性关节炎的发病机制很重要。此外,现有的和潜在的血管生成抑制药物可能对类风湿性关节炎的未来治疗有用。

相似文献

1
Angiogenesis in rheumatoid arthritis: pathogenic and clinical significance.类风湿关节炎中的血管生成:致病及临床意义
J Investig Med. 1998 Feb;46(2):27-41.
2
[Angiotensin and its mediators. Their pathogenic and clinical significance in "angiogenic diseases"].[血管紧张素及其介质。它们在“血管生成性疾病”中的致病及临床意义]
Orv Hetil. 1998 Feb 1;139(5):227-34.
3
[The role of angiogenesis in rheumatoid arthritis].[血管生成在类风湿性关节炎中的作用]
Postepy Hig Med Dosw. 2000;54(6):855-65.
4
Macrophages and their products in rheumatoid arthritis.类风湿关节炎中的巨噬细胞及其产物
Curr Opin Rheumatol. 2007 May;19(3):289-95. doi: 10.1097/BOR.0b013e32805e87ae.
5
Angiogenesis in rheumatoid arthritis.类风湿关节炎中的血管生成
Front Biosci. 2005 May 1;10:1739-53. doi: 10.2741/1657.
6
Regulation of angiogenesis by the C-X-C chemokines interleukin-8 and epithelial neutrophil activating peptide 78 in the rheumatoid joint.类风湿关节中C-X-C趋化因子白细胞介素-8和上皮中性粒细胞激活肽78对血管生成的调节作用
Arthritis Rheum. 2001 Jan;44(1):31-40. doi: 10.1002/1529-0131(200101)44:1<31::AID-ANR5>3.0.CO;2-4.
7
Mechanisms of Disease: angiogenesis in inflammatory diseases.疾病机制:炎症性疾病中的血管生成
Nat Clin Pract Rheumatol. 2007 Nov;3(11):635-43. doi: 10.1038/ncprheum0647.
8
The role of vascular cell adhesion molecule 1/ very late activation antigen 4 in endothelial progenitor cell recruitment to rheumatoid arthritis synovium.血管细胞黏附分子1/极迟活化抗原4在类风湿关节炎滑膜内皮祖细胞募集中的作用
Arthritis Rheum. 2007 Jun;56(6):1817-26. doi: 10.1002/art.22706.
9
Fractalkine in rheumatoid arthritis: a review to date.类风湿关节炎中的趋化因子:最新综述
Rheumatology (Oxford). 2008 Oct;47(10):1446-51. doi: 10.1093/rheumatology/ken197. Epub 2008 May 21.
10
Inhibition of angiogenic pathways in rheumatoid arthritis: potential for therapeutic targeting.类风湿关节炎中血管生成途径的抑制:治疗靶点的潜力。
Best Pract Res Clin Rheumatol. 2006 Oct;20(5):941-7. doi: 10.1016/j.berh.2006.05.004.

引用本文的文献

1
studies of a novel scaffold of benzoxazole derivatives as anticancer agents by 3D-QSAR, molecular docking and molecular dynamics simulations.通过三维定量构效关系、分子对接和分子动力学模拟对一种新型苯并恶唑衍生物支架作为抗癌剂的研究。
RSC Adv. 2023 May 15;13(22):14808-14824. doi: 10.1039/d3ra01316b.
2
Pharmacokinetics-Based Chronoefficacy of and Tripterygium Glycoside Tablet Against Rheumatoid Arthritis.基于药代动力学的白芍总苷和雷公藤多苷片治疗类风湿关节炎的时辰疗效
Front Pharmacol. 2021 May 24;12:673263. doi: 10.3389/fphar.2021.673263. eCollection 2021.
3
Therapeutic Antibody-Like Immunoconjugates against Tissue Factor with the Potential to Treat Angiogenesis-Dependent as Well as Macrophage-Associated Human Diseases.
具有治疗血管生成依赖性以及巨噬细胞相关人类疾病潜力的抗组织因子治疗性抗体样免疫缀合物。
Antibodies (Basel). 2018 Mar;7(1). doi: 10.3390/antib7010008. Epub 2018 Jan 23.
4
Recombinant human endostatin inhibits adjuvant arthritis by down-regulating VEGF expression and suppression of TNF-α, IL-1β production.重组人血管内皮抑制素通过下调 VEGF 表达和抑制 TNF-α、IL-1β 的产生抑制佐剂性关节炎。
Inflamm Res. 2012 Aug;61(8):827-35. doi: 10.1007/s00011-012-0477-z. Epub 2012 May 19.
5
Suppression of endothelial cell activity by inhibition of TNFα.抑制 TNFα 抑制内皮细胞活性。
Arthritis Res Ther. 2012 Apr 25;14(2):R88. doi: 10.1186/ar3812.
6
Vascular endothelial growth factor in children with cyanotic and acyanotic and congenital heart disease.血管内皮生长因子在紫绀型和非紫绀型先天性心脏病患儿中的表达。
Arch Med Sci. 2010 Apr 30;6(2):221-5. doi: 10.5114/aoms.2010.13899.
7
Identification of two new arthritis severity loci that regulate levels of autoantibodies, interleukin-1β, and joint damage in pristane- and collagen-induced arthritis.在 pristane 和胶原诱导的关节炎中,鉴定出两个新的关节炎严重程度基因座,它们可调节自身抗体水平、白细胞介素-1β 水平和关节损伤。
Arthritis Rheum. 2012 May;64(5):1369-78. doi: 10.1002/art.33468.
8
Hypoxia-inducible factors as essential regulators of inflammation.缺氧诱导因子作为炎症的必要调节因子。
Curr Top Microbiol Immunol. 2010;345:105-20. doi: 10.1007/82_2010_74.
9
Angiogenic activity of sera from interstitial lung disease patients in relation to clinical and radiological changes.间质性肺疾病患者血清的血管生成活性与临床和影像学变化的关系。
Eur J Med Res. 2009 Dec 7;14 Suppl 4(Suppl 4):259-64. doi: 10.1186/2047-783x-14-s4-259.
10
Angiogenesis and its targeting in rheumatoid arthritis.类风湿关节炎中的血管生成及其靶向治疗。
Vascul Pharmacol. 2009 Jul;51(1):1-7. doi: 10.1016/j.vph.2009.02.002. Epub 2009 Feb 13.